摘要
目的 探究胸腔内置管腔内注射尿激酶治疗包裹性积液的临床疗效.方法 选取自2012年4月～2013年03月我院收治的包裹性胸腔积液患者100例,每组50例.观察组采用胸腔内置管联合腔内注射尿激素,对照组采用常规胸穿,观察两组患者的疗效及并发症等情况.结果 观察组患者的胸腔积液引流量明显高于对照组,观察组并发症较对照组少很多,观察组患者有效率为92.0%,明显高于对照组56.0%,P＜0.05,具有统计学意义.结论 胸腔内置管联合腔内注射尿激素在包裹性胸腔积液患者的治疗中疗效好,值得推广应用.
Objective To explore the curative effect of chest built-injection of urokinase in the treatment of eneapsulattnt effusion within lumen. Methods 100 patients with encapsulated effusion were randomly and evenly di- vided into two groups. The observation grnup was given chest built-in pipe joint articular injection of urine hormone, and the ennlrnl group was treated with eonvenlinnal lhoraeentesis. Their curative effect and cnmplicalions were observed. Results The drainage was significantly higher in the observation group than irt the control group, and the complications were less in the observalion grnup than in the control group. The effective rate was 92.0% in the nhser- valiotl group and 56. 0% in the control grnup （ P 〈0. 05）. Conclusion Pleural catheler cnmbined wilh intracavilary injection of urine hormone is effective in the lreatmenl of palients with erwapsulaled pleural effusion.
出处
《临床肺科杂志》
2014年第1期89-91,共3页
Journal of Clinical Pulmonary Medicine
关键词
常规胸穿
胸腔内置管
尿激酶
包裹性积液
conventional thoraeentesis
chesl eavily inlulmtinn
encapsulated effusion
urokinase
